Legal & General Group
RVLP

Legal & General Group’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Legal & General Group’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,581
Closed -$5K – 3698
2021
Q1 		$5K Hold
1,581
– – ﹤0.01% 3486
2020
Q4 		$7K Hold
1,581
– – ﹤0.01% 3414
2020
Q3 		$9K Sell
1,581
-122
-7% -$703 ﹤0.01% 3282
2020
Q2 		$11K Buy
1,703
+316
+23% +$1.55K ﹤0.01% 3294
2020
Q1 		$5K Sell
1,387
-133
-9% -$708 ﹤0.01% 3272
2019
Q4 		$11K Hold
1,520
– – ﹤0.01% 3285
2019
Q3 		$6K Hold
1,520
– – ﹤0.01% 3320
2019
Q2 		$5K Hold
1,520
– – ﹤0.01% 3449
2019
Q1 		$6K Hold
1,520
– – ﹤0.01% 3303
2018
Q4 		$12K Buy
+1,520
New +$12.2K ﹤0.01% 3240

Other funds holding RVLP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Legal & General Group's RVLP Position: Q2 2021 in Review

Legal & General Group sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q2 2021, closing a stake of 1,581 shares — an estimated $5K sold.

Legal & General Group first reported a position in RVLP in Q4 2018 and held it in 10 quarters. The position peaked at $12K in Q4 2018. 46 funds tracked by Wall St. Rank hold RVLP as of Q2 2021.

  • Legal & General Group reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 1,581 RVL Pharmaceuticals plc Ordinary Shares shares in Q2 2021, an estimated $5K.
  • Legal & General Group first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2018 and held it in 10 quarters.
  • Legal & General Group's RVL Pharmaceuticals plc Ordinary Shares position peaked at $12K in Q4 2018.
  • 46 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.